Literature DB >> 16937465

HepG2 cells support viral replication and gene expression of hepatitis C virus genotype 4 in vitro.

Mostafa K el-Awady1, Ashraf A Tabll, Yasmine S el-Abd, Mahmoud M Bahgat, Hussein A Shoeb, Samar S Youssef, Noha G Bader el-Din, el-Rashdy M Redwan, Maha el-Demellawy, Moataza H Omran, Wael T el-Garf, Said A Goueli.   

Abstract

AIM: To establish a cell culture system with long-term replication of hepatitis C virus (HCV) genome and expression of viral antigens in vitro.
METHODS: HepG2 cell line was tested for its susceptibility to HCV by incubation with a serum from a patient with chronic hepatitis C. Cells and supernatant were harvested at various time points during the culture. Culture supernatant was tested for its ability to infect naive cells. The presence of minus (antisense) RNA strand, and the detection of core and E1 antigens in cells were examined by RT-PCR and immunological techniques (flow cytometry and Western blot) respectively.
RESULTS: The intracellular HCV RNA was first detected on d 3 after infection and then could be consistently detected in both cells and supernatant over a period of at least three months. The fresh cells could be infected with supernatant from cultured infected cells. Flow cytometric analysis showed surface and intracellular HCV antigen expression using in house made polyclonal antibodies (anti-core, and anti-E1). Western blot analysis showed the expression of a cluster of immunogenic peptides at molecular weights extended between 31 and 45 kDa in an one month old culture of infected cells whereas this cluster was undetectable in uninfected HepG2 cells.
CONCLUSION: HepG2 cell line is not only susceptible to HCV infection but also supports its replication in vitro. Expression of HCV structural proteins can be detected in infected HepG2 cells. These cells are also capable of shedding viral particles into culture media which in turn become infectious to uninfected cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16937465      PMCID: PMC4087617          DOI: 10.3748/wjg.v12.i30.4836

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  35 in total

1.  Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA.

Authors:  A A Kolykhalov; E V Agapov; K J Blight; K Mihalik; S M Feinstone; C M Rice
Journal:  Science       Date:  1997-07-25       Impact factor: 47.728

2.  Antibody to E1 peptide of hepatitis C virus genotype 4 inhibits virus binding and entry to HepG2 cells in vitro.

Authors:  Mostafa K El-Awady; Ashraf A Tabll; Khaled Atef; Samar S Yousef; Moataza H Omran; Yasmin El-Abd; Noha G Bader-Eldin; Ahmad M Salem; Samir F Zohny; Wael T El-Garf
Journal:  World J Gastroenterol       Date:  2006-04-28       Impact factor: 5.742

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Dynamic analysis of hepatitis C virus replication and quasispecies selection in long-term cultures of adult human hepatocytes infected in vitro.

Authors:  Sylvie Rumin; Pascale Berthillon; Eiji Tanaka; Kendo Kiyosawa; Mary-Anne Trabaud; Thierry Bizollon; Christian Gouillat; Philippe Gripon; Christiane Guguen-Guillouzo; Geneviève Inchauspé; Christian Trépo
Journal:  J Gen Virol       Date:  1999-11       Impact factor: 3.891

5.  Comparison between subgenomic replicons of hepatitis C virus genotypes 2a (JFH-1) and 1b (Con1 NK5.1).

Authors:  Michiko Miyamoto; Takanobu Kato; Tomoko Date; Masashi Mizokami; Takaji Wakita
Journal:  Intervirology       Date:  2006       Impact factor: 1.763

Review 6.  Novel cell culture systems for the hepatitis C virus.

Authors:  R Bartenschlager; V Lohmann
Journal:  Antiviral Res       Date:  2001-10       Impact factor: 5.970

7.  Coordinated assembly of human translation initiation complexes by the hepatitis C virus internal ribosome entry site RNA.

Authors:  Hong Ji; Christopher S Fraser; Yonghao Yu; Julie Leary; Jennifer A Doudna
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-24       Impact factor: 11.205

8.  Recurrent hepatitis C virus infection after liver transplantation: immunohistochemical assessment of the viral antigen.

Authors:  V Vargas; K Krawczynski; L Castells; N Martinez; J Esteban; H Allende; R Esteban; J Guardia
Journal:  Liver Transpl Surg       Date:  1998-07

9.  Reproducible high level infection of cultured adult human hepatocytes by hepatitis B virus: effect of polyethylene glycol on adsorption and penetration.

Authors:  P Gripon; C Diot; C Guguen-Guillouzo
Journal:  Virology       Date:  1993-02       Impact factor: 3.616

10.  Interaction of hepatitis C virus-like particles and cells: a model system for studying viral binding and entry.

Authors:  Miriam Triyatni; Bertrand Saunier; Padma Maruvada; Anthony R Davis; Luca Ulianich; Theo Heller; Arvind Patel; Leonard D Kohn; T Jake Liang
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

View more
  25 in total

1.  Very-low-density lipoprotein (VLDL)-producing and hepatitis C virus-replicating HepG2 cells secrete no more lipoviroparticles than VLDL-deficient Huh7.5 cells.

Authors:  Baptiste Jammart; Maud Michelet; Eve-Isabelle Pécheur; Romain Parent; Birke Bartosch; Fabien Zoulim; David Durantel
Journal:  J Virol       Date:  2013-02-20       Impact factor: 5.103

2.  Inhibition of core gene of HCV 3a genotype using synthetic and vector derived siRNAs.

Authors:  Saba Khaliq; Shah Jahan; Bushra Ijaz; Waqar Ahmad; Sultan Asad; Asim Pervaiz; Baila Samreen; Mahwish Khan; Sajida Hassan
Journal:  Virol J       Date:  2010-11-13       Impact factor: 4.099

3.  Anti-infectivity of camel polyclonal antibodies against hepatitis C virus in Huh7.5 hepatoma.

Authors:  Esmail M El-Fakharany; Nawal Abedelbaky; Bakry M Haroun; Lourdes Sánchez; Nezar A Redwan; Elrashdy M Redwan
Journal:  Virol J       Date:  2012-09-16       Impact factor: 4.099

4.  Post-transcriptional inhibition of hepatitis C virus replication through small interference RNA.

Authors:  Usman Ali Ashfaq; Muhammad Ansar; Muhammad Tahir Sarwar; Tariq Javed; Sidra Rehman; Sheikh Riazuddin
Journal:  Virol J       Date:  2011-03-10       Impact factor: 4.099

5.  Role of HCV Core gene of genotype 1a and 3a and host gene Cox-2 in HCV-induced pathogenesis.

Authors:  Shah Jahan; Saba Khaliq; Bushra Ijaz; Waqar Ahmad; Sajida Hassan
Journal:  Virol J       Date:  2011-04-01       Impact factor: 4.099

6.  In-vitro antiviral activity of Solanum nigrum against Hepatitis C Virus.

Authors:  Tariq Javed; Usman Ali Ashfaq; Sana Riaz; Sidra Rehman; Sheikh Riazuddin
Journal:  Virol J       Date:  2011-01-19       Impact factor: 4.099

7.  Inhibition of full length hepatitis C virus particles of 1a genotype through small interference RNA.

Authors:  Muhammad Ansar; Usman Ali Ashfaq; Imran Shahid; Muhammad Tahir Sarwar; Tariq Javed; Sidra Rehman; Sajida Hassan; Sheikh Riazuddin
Journal:  Virol J       Date:  2011-05-02       Impact factor: 4.099

8.  Characterization of chronic HCV infection-induced apoptosis.

Authors:  Abdel-Rahman N Zekri; Abeer A Bahnassy; Mohamed M Hafez; Zeinab K Hassan; Mahmoud Kamel; Samah A Loutfy; Ghada M Sherif; Abdel-Rahman El-Zayadi; Sayed S Daoud
Journal:  Comp Hepatol       Date:  2011-07-23

9.  Consensus siRNA for inhibition of HCV genotype-4 replication.

Authors:  Abdel Rahman N Zekri; Abeer A Bahnassy; Hanaa M Alam El-Din; Hosny M Salama
Journal:  Virol J       Date:  2009-01-27       Impact factor: 4.099

10.  Effectiveness of human, camel, bovine and sheep lactoferrin on the hepatitis C virus cellular infectivity: comparison study.

Authors:  Esmail M El-Fakharany; Lourdes Sánchez; Hussein A Al-Mehdar; Elrashdy M Redwan
Journal:  Virol J       Date:  2013-06-19       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.